Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
2024-11-05

DJ Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. $(INO)$ rose 1.28% to $5.52 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.33% to 18,179.98 and Dow Jones Industrial Average falling 0.61% to 41,794.60.

This was the stock's second consecutive day of gains.

Inovio Pharmaceuticals Inc. closed $9.23 below its 52-week high ($14.75), which the company achieved on April 1st.

The stock outperformed some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 1.18% to $158.24, Statera Biopharma Inc. (STAB) fell 33.33% to $0.00, and Pfizer Inc. $(PFE)$ fell 1.17% to $27.76.

Trading volume (218,858) remained 73,207 below its 50-day average volume of 292,065.

Data source: Dow Jones Market Data, FactSet. Data compiled November 4, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 04, 2024 17:27 ET (22:27 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10